U.S. SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 12B-25
NOTIFICATION OF LATE FILING
SEC File Number 000-29461
Form 10-QSB
For Period Ending: 09/30/05
- --------------------------------------------------------------------------------
PART I: REGISTRANT INFORMATION
- --------------------------------------------------------------------------------
Full Name of Registrant: Organetix, Inc. ("OGTX")
Address of Principal Executive Office: 603 - 7th Avenue S.W. - Suite 200,
Calgary, Alberta, Canada T2P 2T5 Phone - (403) 261-8888 ext. 224
- --------------------------------------------------------------------------------
PART II: RULES 12B-25(B) AND (C)
- --------------------------------------------------------------------------------
It is anticipated that the subject Quarterly Report on Form 10-QSB will be filed
within the next several days.
- --------------------------------------------------------------------------------
PART III: NARRATIVE
- --------------------------------------------------------------------------------
The Registrant has not completed its Quarterly Report on Form 10-QSB for the
period ended September 30, 2005, due to administrative delays.
- --------------------------------------------------------------------------------
PART IV: OTHER INFORMATION
- --------------------------------------------------------------------------------
(1) Name and telephone number of person(s) to contact in regard to this
notification
L. B. (Brad) Clarke, Chief Executive Officer (403) 261-8888
(2) Have all other periodic reports required under section 13 or 15(d) of the
Securities Exchange Act of 1934 or section 30 of the Investment Company Act of
1940 during the preceding 12 months or for such shorter period that the
Registrant was required to file such report(s) been filed? If the answer is no,
identify report(s).
[X] YES [ ] NO
(3) Is it anticipated that any significant change in results of operations from
the corresponding period for the last fiscal year will be reflected by the
earnings statements to be included in the subject report or portion thereof?
[ ] YES [X] NO
If so, attach an explanation of the anticipated change, both narratively and
quantitatively, and, if appropriate, state the reasons why a reasonable estimate
of the results cannot be made. Organetix, Inc. has caused this notification to
be signed on its behalf by the undersigned thereunto duly authorized.
Dated: November 14, 2005
ORGANETIX, INC.
By: /s/ L. B. (Brad) Clarke
-----------------------
L. B. (Brad) Clarke,
President